US equities |
MU $904.90 ▲+2.97% NVDA $217.09 ▲+1.38% AMZN $262.45 ▲+4.98% TSLA $368.06 ▲+3.76% AAPL $342.94 ▼-0.15% SNDK $1,371.12 ▲+5.53% META $705.44 ▼-0.55% SPCX $147.96 ▲+1.32%
FinancialContent

Latest News about Srinivas Rao

Recent news which mentions Srinivas Rao

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Tickers ATAI DMT MDMA NEWS
Tags Benzinga DMT Psychedelics Research
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Tickers ATAI ENVB NEWS
Tags Joseph Tucker News Market News
From Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags DMT/Assisted Therapy Health Care DMT Clinical Trial
From Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Tickers ATAI HTGC
Tags Cannabis News Market News
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags VEGGF BMBIF OPTHF
From Benzinga